chr17-39462983-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6BP7BS2
The NM_016507.4(CDK12):āc.912C>Gā(p.Pro304=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0033 in 1,614,164 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: š 0.0021 ( 0 hom., cov: 32)
Exomes š: 0.0034 ( 6 hom. )
Consequence
CDK12
NM_016507.4 synonymous
NM_016507.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0200
Genes affected
CDK12 (HGNC:24224): (cyclin dependent kinase 12) Enables RNA polymerase II CTD heptapeptide repeat kinase activity and cyclin binding activity. Involved in phosphorylation of RNA polymerase II C-terminal domain; protein autophosphorylation; and regulation of MAP kinase activity. Located in nuclear speck. Part of cyclin K-CDK12 complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant 17-39462983-C-G is Benign according to our data. Variant chr17-39462983-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 3035867.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=0.02 with no splicing effect.
BS2
High AC in GnomAd4 at 327 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CDK12 | NM_016507.4 | c.912C>G | p.Pro304= | synonymous_variant | 1/14 | ENST00000447079.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CDK12 | ENST00000447079.6 | c.912C>G | p.Pro304= | synonymous_variant | 1/14 | 1 | NM_016507.4 | P4 | |
CDK12 | ENST00000430627.6 | c.912C>G | p.Pro304= | synonymous_variant | 1/14 | 1 | A1 | ||
CDK12 | ENST00000584632.5 | c.912C>G | p.Pro304= | synonymous_variant | 1/13 | 5 | |||
CDK12 | ENST00000559663.2 | c.912C>G | p.Pro304= | synonymous_variant, NMD_transcript_variant | 1/21 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00215 AC: 327AN: 152164Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
327
AN:
152164
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00154 AC: 386AN: 251238Hom.: 1 AF XY: 0.00148 AC XY: 201AN XY: 135824
GnomAD3 exomes
AF:
AC:
386
AN:
251238
Hom.:
AF XY:
AC XY:
201
AN XY:
135824
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00342 AC: 5002AN: 1461882Hom.: 6 Cov.: 32 AF XY: 0.00325 AC XY: 2361AN XY: 727244
GnomAD4 exome
AF:
AC:
5002
AN:
1461882
Hom.:
Cov.:
32
AF XY:
AC XY:
2361
AN XY:
727244
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00215 AC: 327AN: 152282Hom.: 0 Cov.: 32 AF XY: 0.00207 AC XY: 154AN XY: 74456
GnomAD4 genome
AF:
AC:
327
AN:
152282
Hom.:
Cov.:
32
AF XY:
AC XY:
154
AN XY:
74456
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
CDK12-related disorder Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 05, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at